US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
JBS NV (Z98) 銘柄情報

JBS NV (Z98)

10.55

-0.165

( -1.54% )

更新日時： 03:03:01

JBS NV (Z98) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

10.55

( -1.54% )

買値

10.575

売値

10.645

出来高

388

10.55 日の範囲 10.81

10.00 52 週間の範囲 15.805

時価総額

前日終値

10.715

始値

10.81

時刻

最終取引時間

00:19:12

財務取引量

-

VWAP

-

平均取引量 (3 か月)

7,115,914 €

発行済株式数

1,070,876,863

配当利回り

1 (15.55%)

PER

7.56

1 株当たり利益 (EPS)

1.62

歳入

88.27B

純利益

1.74B

JBS N.V., together with its subsidiaries, engages in the processing of animal proteins, encompassing activities related to beef, pork, lamb, and poultry worldwide. The company is involved in the production and marketing of prepared foods and other related products, as well as operations in leather, ... JBS N.V., together with its subsidiaries, engages in the processing of animal proteins, encompassing activities related to beef, pork, lamb, and poultry worldwide. The company is involved in the production and marketing of prepared foods and other related products, as well as operations in leather, collagen, hygiene and beauty products, metal packaging, biodiesel, and other related businesses. It offers its products under the Seara, Doriana, Pilgrim’s, Moy Park, Primo, Friboi, Maturatta, Swift, Ozo, Adaptable Meals, and other brand names. The company was founded in 1953 and is based in Amstelveen, the Netherlands. 詳細を表示

セクター

-

業界

-

ウェブサイト

jbsglobal.com

本社

Amstelveen, Netherlands

設立

2026

JBS NV is listed in the sector of the Tradegate (DE) with ticker Z98. The last closing price for JBS NV was 10.72 €. Over the last year, JBS NV shares have traded in a share price range of 10.00 € to 15.805 €.

JBS NV currently has 1,070,876,863 shares in issue. The market capitalisation of JBS NV is 11.30 € billion. JBS NV has a price to earnings ratio (PE ratio) of 7.56.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.15	1.44230769231	10.4	10.81	10.4	1136	10.51250103	DE
4	-0.11	-1.03189493433	10.66	10.98	10	2284	10.38273265	DE
12	-5.23	-33.1432192649	15.78	15.78	10	2434	11.26930243	DE
26	-1.25	-10.593220339	11.8	15.805	10	1755	12.01734649	DE
52	-1.645	-13.4891348913	12.195	15.805	10	1392	12.0615502	DE
156	-2.214	-17.3456596678	12.764	15.805	10	1390	12.06593238	DE
260	-2.214	-17.3456596678	12.764	15.805	10	1390	12.06593238	DE

Z98 - Frequently Asked Questions (FAQ)

What is the current JBS NV share price?

The current share price of JBS NV is 10.55 €

How many JBS NV shares are in issue?

JBS NV has 1,070,876,863 shares in issue

What is the market cap of JBS NV?

The market capitalisation of JBS NV is EUR 11.3B

What is the 1 year trading range for JBS NV share price?

JBS NV has traded in the range of 10.00 € to 15.805 € during the past year

What is the PE ratio of JBS NV?

The price to earnings ratio of JBS NV is 7.56

What is the cash to sales ratio of JBS NV?

The cash to sales ratio of JBS NV is 0.15

What is the registered address of JBS NV?

The registered address for JBS NV is Stroombaan 16, Amstelveen, Noord-Holland, 1181 VX

What is the JBS NV website address?

The website address for JBS NV is jbsglobal.com

JJ24

Would be nice to see some volume before update . It’s gotta be something super juicy to get a group to buy .

z-money

z-money 2分前

I being impatient, I know. But I wish they would get their act together already. LOL.

SDCRBS

⭐ Executive Summary: Melvin Ejiogu (CEO, VeeMost Technologies)
🎓 Education & Credentials
Melvin holds a Bachelor’s degree in Business Administration (Corporate Finance) from the University of Akron in Ohio .

He also holds top-level IT certifications, including th

stevhoff

stevhoff 2分前

Series E preferred:3,898,500. Each share convertibl;e into 1000 shares of common.

US Market News

US Market News 3分前

Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular LymphomaJuly 6, 2026 1:45 PM
Business Wire TEPKINLY® (epcori

US Market News

US Market News 3分前

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular LymphomaJuly 6, 2026 1:45 PM
PR Newswire (US) TEPKINLY

US Market News

US Market News 3分前

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular LymphomaJuly 6, 2026 1:45 PM
PR Newswire (US) TEPKINLY

nathanial

nathanial 3分前

Number 1 on the breakout boards.

US Market News

US Market News 3分前

Zoetis Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ZTSJuly 6, 2026 1:50 PM
PR Newswire (US) class="legendSpanClass"LOS ANGELES, class="legendSpanClass"July 6, 2026 /PRNewswire/ --

rmoss

Hell he could be just trying to keep his atm open lol

Aquahoya

Aquahoya 4分前

One more MM. Cant be much

Myth

"Blacktop Horizon" Justin Johnson live

https://www.youtube.com/watch?v=uElBgnt45RA

jimmybob

jimmybob 4分前

Samsung earnings tonight which means the Kospi will be up 873% or down 416%.

And then collateral damage or impacts to $MU $STX $WDC $QQQ etc. tomorrow

quigley24

quigley24 4分前

I agree and maybe more...................go Sury

Red_Right_Hand

Red_Right_Hand 4分前

As I said before, it can reasonably be surmised that this was after January 1, 2026 both because of some data/work added and done in the slide deck, and, more importantly, because it must have come after the second CHM meeting on DCVax-L at the end of November 2025.

Nothing you've poi

vlispxpert

vlispxpert 5分前

Keep eye on this one:

https://schrts.co/wcqIKvjp

MightyX

MightyX 6分前

On positive note..yalls good cop/bad cop routine’s still hilarious..to-the-public.

stoxjock

stoxjock 6分前

LG, What do you think is gonna happen with 'L1" shares? Do you think we'll have an 8-K after 2 days? I am hoping something shows up this Wed/Thursday...
TIA & GLTU!

KngmAz

We're going up - Just the beginning - Nice.

William777

William777 6分前

If "monetary penalty" is low, NNRX could be ready for blastoff in the next 10 minutes.

surfer44

surfer44 6分前

The Small-Cap Rally is REAL: Don't Miss This 23% Gains ETF!

https://youtu.be/mRfTE4azPM0

Monksdream

Monksdream 7分前

INLIF Ltd. is a holding company, which engages in the development of injection molding machine-dedicated manipulator arms. Its products include: Three-axis robot, Five-axis robot, and bull head type manipulator. The company was founded on January 4, 2023 and is headquartered in Quanzhou, China. The

bobby1151

bobby1151 7分前

I like & use this (as U call "a piece of puppy dawg dooo) company's product's 4 my pain issues & their products WORK 4 me 4 over 15 years- GO BIEL!!!!!!!

blownaccount9

blownaccount9 7分前

Remember when we were all calculating damages checks and we were getting dollars per preferred share? How was that math working out? There are 1.3 billion shares if we average out all the series to $25 par. Looks to me like $1 is the max per $25/par with the more likely outcome closer to $0.65 cents

gladeshawk

gladeshawk 7分前

Patience required. I have it, and I can wait. Any good news and SURY is a 10x-20x play. IMHO, HAWK

Global X MSCI Greece ETF

Amundi Euro Government G...

Banco Santander Chile

DJ Commodity Index Indus...

Whitehall Jewel

Genesis Growth Tech Acqu...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。